Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Scroll down to content

Posts

Posted on 7 January 20207 January 2020

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
  • FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
  • FDA Approves Spravato (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
  • FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

RSS Pharma Manufacturing News

  • Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
  • ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
  • J&J announces agreement with US govt for 100 million doses of investigational Covid-19 vaccine

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • A 4-point guide to rethinking your digital health care strategy
  • Virtual Care: Innovations and Efficiencies for Clinicians, Patients and Administrators on the Microsoft Platform
  • Spotlight Series: Artificial Intelligence and Machine Learning
  • Rapid Deployment, Multi-Cloud Strategies Growing Among Healthcare Organizations
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok